Gene · 3274
Papers2,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies. | Cancers (Basel) | 2022 | 35267558 | PubTator, text mining | PubMed |
| The role of human mast cells in allergy and asthma. | Bioengineered | 2022 | 35266441 | PubTator, text mining | PubMed |
| Neuroendocrine Regulation of Stress-Induced T Cell Dysfunction during Lung Cancer Immunosurveillance via the Kisspeptin/GPR54 Signaling Pathway. | Adv Sci (Weinh) | 2022 | 35224894 | PubTator, text mining | PubMed |
| Population pharmacokinetics of crenolanib in children and young adults with brain tumors. | Cancer Chemother Pharmacol | 2022 | 35212779 | PubTator, text mining | PubMed |
| Histamine H2 Receptor Antagonists and Heart Failure Risk in Postmenopausal Women: The Women's Health Initiative. | J Am Heart Assoc | 2022 | 35191329 | PubTator, text mining | PubMed |
| Novel inhibitors of phosphorylation independent activity of GRK2 modulate cAMP signaling. | Pharmacol Res Perspect | 2022 | 35184416 | PubTator, text mining | PubMed |
| Effectiveness of Cimetidine as Adjuvant Therapy in the Treatment of Acute-Extrinsic Atopic Dermatitis: A Double-Blind Randomized Controlled Trial. | Dermatol Ther (Heidelb) | 2022 | 35175572 | PubTator, text mining | PubMed |
| Why Monoamine Oxidase B Preferably Metabolizes N-Methylhistamine over Histamine: Evidence from the Multiscale Simulation of the Rate-Limiting Step. | Int J Mol Sci | 2022 | 35163835 | PubTator, text mining | PubMed |
| Effect of Ions and Sequence Variants on the Antagonist Binding Properties of the Histamine H1 Receptor. | Int J Mol Sci | 2022 | 35163341 | PubTator, text mining | PubMed |
| Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives. | Cancers (Basel) | 2022 | 35158915 | PubTator, text mining | PubMed |
| Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial. | Gut | 2022 | 35144974 | PubTator, text mining | PubMed |
| Cost Effectiveness of Pharmacological Management for Osteoarthritis: A Systematic Review. | Appl Health Econ Health Policy | 2022 | 35138600 | PubTator, text mining | PubMed |
| Role of histidine decarboxylase gene in the pathogenesis of Tourette syndrome. | Brain Behav | 2022 | 35114079 | PubTator, text mining | PubMed |
| Management of Bladder Pain Syndrome (BPS): A Practical Guide. | Adv Urol | 2022 | 35047038 | PubTator, text mining | PubMed |
| Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial. | Eur Arch Otorhinolaryngol | 2022 | 35032204 | PubTator, text mining | PubMed |
| Epigallocatechin gallate stimulated histamine production and downregulated histamine H1 receptor in oral cancer cell lines expressing histidine decarboxylase. | J Oral Biosci | 2022 | 35031480 | PubTator, text mining | PubMed |
| Abnormal sperm morphology is associated with sensitization to inhaled allergens. | Int J Immunopathol Pharmacol | 2022 | 34984934 | PubTator, text mining | PubMed |
| Role of Glucose Breath Test for Small Intestinal Bacterial Overgrowth in Children and Adolescents With Functional Abdominal Pain Disorders in Korea. | J Neurogastroenterol Motil | 2022 | 34980690 | PubTator, text mining | PubMed |
| Different genes may be involved in distal and local sensitization: A genome-wide gene-based association study and meta-analysis. | Eur J Pain | 2022 | 34958702 | PubTator, text mining | PubMed |
| Structural and Molecular Insight into Piperazine and Piperidine Derivatives as Histamine H3 and Sigma-1 Receptor Antagonists with Promising Antinociceptive Properties. | ACS Chem Neurosci | 2022 | 34908391 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3274/papers?page=16